Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Renal denervation is 'highly unlikely,' says Medtronic study insider
Mass Device
Friday, January 17, 2014 - 9:01am
tags:
Medtronic, renal denervation
Pharma Critics Want Complete Clinical Trial Transparency, Yet Want To Ban Publishing Pharma Funded Studies
Forbes
Friday, January 17, 2014 - 8:46am
tags:
clinical trials, transparency, R&D
Look for Teva's new chief to move fast on dealmaking, CFO says
Fierce Pharma
Friday, January 17, 2014 - 8:44am
tags:
Teva, M&A, Erez Vigodman
Roche resolves shortage of liquid Tamiflu
Fierce Pharma
Friday, January 17, 2014 - 8:43am
tags:
Roche, Tamiflu, drug shortages, Flu
Shire takes $650 mln hit on Dermagraft sale
Reuters
Friday, January 17, 2014 - 8:41am
tags:
Dermagraft, Shire, Organogenesis
J&J Continues ‘Strategic Pruning’ With This Divestiture
Wall St Cheat Sheet
Friday, January 17, 2014 - 8:40am
tags:
JNJ, diagnostics, Ortho Clinical Diagnostics, Carlyle
ArQule shares rise after committee say liver cancer study can continue with lower drug dose
Yahoo/AP
Friday, January 17, 2014 - 8:39am
tags:
Arqule, liver cancer, FDA, tivantinib
Sanofi's LixiLan Progresses
Yahoo/Zacks.com
Friday, January 17, 2014 - 8:37am
tags:
Sanofi, LixiLan, insulin, Lantus, diabetes, Zealand Pharma, Lyxumia
Chelsea Therapeutics May Be A Revenue Generating Biotech By The End Of 2014
Seeking Alpha
Friday, January 17, 2014 - 8:36am
tags:
Chelsea Therapeutics, Northera
Google develops contact lens glucose monitor; could end finger pricks for diabetics
Yahoo/AP
Friday, January 17, 2014 - 8:28am
tags:
Google, diabetes, blood glucose monitoring, glucose monitors, devices, Google X
FDA advisory panel rejects J&J drug for acute coronary syndrome
Reuters
Thursday, January 16, 2014 - 4:54pm
tags:
JNJ, acute coronary syndrome, Xarelto, advisory panels, FDA
Novartis may finally face generic competition for Diovan
Fierce Pharma
Thursday, January 16, 2014 - 4:53pm
tags:
Diovan, Novartis, generics, Ranbaxy, hypertension
Boston Scientific Says It Will Pause Hypertension Trial
Bloomberg
Thursday, January 16, 2014 - 4:49pm
tags:
Boston Scientific, hypertension, Vessix, Medtronic, devices
Solid 2014 Expected for Shire
Yahoo/Zacks.com
Thursday, January 16, 2014 - 4:48pm
tags:
Shire
[video] Biotech: 2014's favored child
CNBC
Thursday, January 16, 2014 - 4:47pm
tags:
biotech
Key Pharmaceutical Stocks Ready to Deliver Earnings Beats
Yahoo/Zacks.com
Thursday, January 16, 2014 - 11:44am
tags:
earnings, Forest Labs, JNJ, Ironwood
Foundation Medicine: A Unique Cancer Play Backed By Google Ventures
Wall St Cheat Sheet
Thursday, January 16, 2014 - 11:39am
tags:
Foundation Medicine, Google, cancer
Sarepta jumps on fresh optimism for an early approval
Fierce Biotech
Thursday, January 16, 2014 - 11:34am
tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen
Ampio Pharmaceuticals Starts Final Study for Osteoarthritis Treatment
Motley Fool
Thursday, January 16, 2014 - 11:30am
tags:
Ampio Pharmaceuticals, osteoarthritis, Ampion
Searching Genes to Avoid Medical Side Effects: Can patients' DNA warn doctors against prescribing antidepressants, other drugs?
WSJ Online
Thursday, January 16, 2014 - 11:28am
tags:
genes, personalized medicine, FDA, antidepressants

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.